![Kristie Burns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristie Burns
Hoofd Techniek/Wetenschap/O&O bij TACTILE SYSTEMS TECHNOLOGY, INC.
Vermogen: 796 567 $ op 31-05-2024
Profiel
Kristie T.
Burns is currently the Senior Vice President-Marketing & Clinical Affairs at Tactile Systems Technology, Inc. Prior to this, she worked as the GM-Dental Sleep & Public Relations Contact at ResMed, Inc. and as the Chief Marketing Officer at Cala Health, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
06-05-2024 | 62 574 ( 0.26% ) | 796 567 $ | 31-05-2024 |
Actieve functies van Kristie Burns
Bedrijven | Functie | Begin |
---|---|---|
TACTILE SYSTEMS TECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 22-03-2021 |
Eerdere bekende functies van Kristie Burns
Bedrijven | Functie | Einde |
---|---|---|
Cala Health, Inc.
![]() Cala Health, Inc. Hospital/Nursing ManagementHealth Services Cala Health, Inc. operates as a bioelectronic medicine company. It develops wearable neuromodulation therapies. The company was founded by Kathryn Rosenbluth, Scott Delp and Serena Wong in 2014 and is headquartered in Burlingame, CA. | Verkoop & Marketing | - |
RESMED, INC. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
RESMED, INC. | Health Technology |
TACTILE SYSTEMS TECHNOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Cala Health, Inc.
![]() Cala Health, Inc. Hospital/Nursing ManagementHealth Services Cala Health, Inc. operates as a bioelectronic medicine company. It develops wearable neuromodulation therapies. The company was founded by Kathryn Rosenbluth, Scott Delp and Serena Wong in 2014 and is headquartered in Burlingame, CA. | Health Services |